Skip to content

Medicine Matters

Sharing successes, challenges and daily happenings in the Department of Medicine

Article of the Week

Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis

ARTICLE: Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis AUTHORS: Oliver G McDonald, Xin Li, Tyler Saunders, Rakel Tryggvadottir, Samantha… Read More »Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis

Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes

ARTICLE: Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes AUTHORS: Peter M. Abadir, Alka Jain, Laura J. Powell, Qian-Li Xue, Jing Tian, Robert G. Hamilton, David… Read More »Discovery and Validation of Agonistic Angiotensin Receptor Autoantibodies as Biomarkers of Adverse Outcomes

Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

ARTICLE: Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy AUTHORS: Thomas P. Mast, Cynthia A. James, Hugh Calkins, Arco J. Teske, Crystal Tichnell, Brittney Murray, Peter Loh, Stuart D. Russell, Birgitta K. Velthuis, Daniel P. Judge, Dennis Dooijes, Ryan J. Tedford, Jeroen F. van der Heijden, Harikrishna Tandri, Richard N. Hauer, Theodore P. Abraham, Pieter A. Doevendans, Anneline… Read More »Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis

ARTICLE: Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis. AUTHORS: Emily A Kendall, Anthony T Fojo, David W Dowdy JOURNAL:… Read More »Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis